Clinical Trials
4 trialsNCT04015700 2026-05-07
Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Washington University School of Medicine
Phase 1 Active not recruiting
NCT03491683 2026-05-04
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
Inovio Pharmaceuticals
Phase 1/2 Active not recruiting
NCT02772003 2026-04-13
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
National Cancer Institute (NCI)
Phase 1 Active not recruiting
NCT04367675 2026-02-23
INO 5401 Vaccination in BRCA1/2 Mutation Carriers
Abramson Cancer Center at Penn Medicine
Phase 1 Active not recruiting